Notable Labs, Ltd. (NTBLQ)

OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0240 (-44.44%)
Nov 13, 2024, 3:00 PM EST
-80.77%
Market Cap 289.79K
Revenue (ttm) 313.00K
Net Income (ttm) -10.54M
Shares Out 9.66M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 133,008
Open 0.0535
Previous Close 0.0540
Day's Range 0.0121 - 0.0600
52-Week Range 0.0121 - 4.2400
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company’s pipeline includes... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 16
Stock Exchange OTCMKTS
Ticker Symbol NTBLQ
Full Company Profile

Financial Performance

In 2023, Notable Labs's revenue was $310,000, an increase of 3775.00% compared to the previous year's $8,000. Losses were -$11.26 million, -21.82% less than in 2022.

Financial Statements

News

There is no news available yet.